Summa Corp’s Abbott ABT Stock Holding History

Summa Corp’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,691	Closed	-$226K	–	78
2025 Q3	$226K	Sell	1,691 -522	-24%	-$68.5K	0.1%	71
2025 Q2	$301K	Hold	2,213	–	–	0.16%	60
2025 Q1	$294K	Hold	2,213	–	–	0.17%	53
2024 Q4	$250K	Hold	2,213	–	–	0.12%	56
2024 Q3	$252K	Hold	2,213	–	–	0.12%	57
2024 Q2	$230K	Hold	2,213	–	–	0.11%	60
2024 Q1	$252K	Buy	+2,213	New	+$254K	0.14%	57

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Summa Corp's ABT Position: Q4 2025 in Review

Summa Corp sold out of Abbott (ABT) in Q4 2025, closing a stake of 1,691 shares — an estimated $226K sold.

Summa Corp first reported a position in ABT in Q1 2024 and held it in 7 quarters. The position peaked at $301K in Q2 2025. 3,284 funds tracked by Wall St. Rank hold ABT as of Q4 2025.

Summa Corp reported no remaining Abbott position as of Q4 2025 after selling out during the quarter.
Summa Corp sold 1,691 Abbott shares in Q4 2025, an estimated $226K.
Summa Corp first reported a position in Abbott in Q1 2024 and held it in 7 quarters.
Summa Corp's Abbott position peaked at $301K in Q2 2025.
3,284 funds tracked by Wall St. Rank held Abbott as of Q4 2025.

Based on Summa Corp's 13F filing for Q4 2025, filed 21 Jan 2026.